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mutations associated with Dent’sJapan disease.
Background. The annual urinary screening of Japanese children
above three years of age has identified a progressive renal tubular
disorder characterized by low molecular weight proteinuria, hy-
percalciuria and nephrocalcinosis, and this represents a variant of
Dent’s disease. Hitherto, 12 mutations of the X-linked renal
specific chloride channel, CLCN5, have been reported in the
Dent’sJapan variant. To further identify such CLCN5 mutations
and to define the structure-function relationships of this channel,
we have investigated five unrelated, non-consanguinous Japanese
families with this disorder.
Methods. Leukocyte DNA from probands was used with
CLCN5 primers for PCR amplification of the coding region, and
the DNA sequences of the products determined. Functional
studies were performed by expressing the mutants in Xenopus
oocytes.
Results. Five CLCN5 mutations consisting of two nonsense
(R648X and R704X), two missense (S270R and L278F) and one
acceptor splice site mutation (ag3cg) in intron 4 were identified.
The missense and splice site mutations represent novel abnormal-
ities. Heterologous expression in Xenopus oocytes of wild-type
and the missense mutants demonstrated that the mutations, which
were translated, either abolished or markedly reduced chloride
conductance.
Conclusions. These results expand the spectrum of CLCN5
mutations associated with this renal disorder and provide insight
into possible structure-function relationships. For example, both
the missense mutations are located within a short putative loop
between two transmembrane domains, and our results suggest
that this region may have an important functional role in the
regulation of channel activity.
Four disorders of hereditary hypercalciuric nephrolithi-
asis that have been referred to as Dent’s disease [1–3],
X-linked recessive neophrolithiasis (XRN) [4, 5], X-linked
recessive hypophosphataemic rickets (XLRH) [6], and the
idiopathic low molecular weight proteinuria of Japanese
children (JILMWP) [7–12], have been reported to be due
to mutations of the X-linked renal specific voltage-gated
chloride channel, CLCN5 [3, 13–18]. All four of these
diseases have features in common and they represent renal
tubular disorders that are characterized by low molecular
weight proteinuria (LMWP), hypercalciuria, nephrocalci-
nosis, nephrolithiasis and renal failure. In addition, other
renal proximal tubular defects, including aminoaciduria,
phosphaturia, glycosuria, kaliuresis, uricosuria and an im-
pairment of urinary acidification, may also occur [1, 4, 6, 7].
However, there are differences between these disorders.
For example, rickets has been a particular feature of Dent’s
disease and XLRH, and severe renal failure has been a
feature of Dent’s disease and XRN [1–7]. Dent’s disease,
XRN and XLRH were mapped to Xp11.22 [2, 5, 6], and a
microdeletion in one patient with Dent’s disease facilitated
the isolation and characterization of a renal chloride chan-
nel gene, CLCN5 [2, 19, 20] (Fig. 1). DNA sequence
analyses identified different CLCN5 mutations, consisting
of nonsense, missense, donor splice site, insertional and
deletional mutations, in patients with these four hypercal-
ciuric nephrolithiasis disorders [3, 13–18], together with
another form of an hereditary renal tubular acidosis [21],
thereby establishing the causal role of CLCN5 in these
diseases [18, 22, 23]. In addition, heterologous expression
of the wild-type CLCN5 gene or its mutants in Xenopus
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oocytes demonstrated that the wild-type channel, CLC-5,
conducted outwardly directed chloride (Cl2) currents that
were either abolished or markedly reduced by the muta-
tions, thereby demonstrating the functional importance of
such mutations [3, 13, 14]. The common genetic etiology of
CLCN5 mutations and the phenotypic similarities between
all these syndromes indicated that they are variants of one
disorder, and it has been proposed to refer to them
collectively as Dent’s disease [3, 15]. The occurrence of the
Japanese variants, referred to as Dent’sJapan [15], has been
reported in more than 60 patients in Japan. These patients
have been identified through the annual urinary screening
program of Japanese children above three years of age
[7–12]. To date CLCN5 mutations in Dent’sJapan disease
have been reported in 12 kindreds [14, 15, 17] and only one
of these has been functionally characterized [14]. We have
therefore undertaken studies to identify additional CLCN5
mutations that may be associated with Dent’sJapan disease
and to functionally characterize them, when appropriate,
with the aim of elucidating further the structure-function
relationships of this novel renal chloride channel.
METHODS
Patients
Thirteen members from five unrelated, non-consangui-
nous Japanese families who were identified from the an-
nual urinary screening program to have b2 microglobinuria
(normal child and adult ,320 mg/liter and ,250 mg/liter,
respectively) were clinically and biochemically assessed for
low molecular weight proteinuria, hypercalciuria and
nephrocalcinosis, as previously described [7, 15]. The de-
tails of the 12 affected members and one unaffected
member from these five families are summarized in Table
1. Venous blood samples were obtained, after informed
consent, from the 13 members and used for mutational
analysis of the CLCN5 gene.
Fig. 1. Schematic representation of a predicted
topology of CLC-5, which consists of 746 amino
acids [13, 19]. The correct topology of CLC
channels is unknown and the predicted
topology of the CLC-5 putative transmembrane
domains (D1-D13) is based upon a model that
places D4 extracellularly, and in which the
hydrophobic core of the D9-D12 region crosses
the membrane three or five times and contains
a hydrophobic region, the precise location of
which remains unknown [26]. The consensus
protein kinase A (PKA) phosphorylation and
glycosylation sites are indicated by the asterisks
and branch signs, respectively. The locations of
the five mutations (Table 2) observed in the
patients with Dent’sJapan disease (Table 1) are
illustrated. These five mutations consist of two
nonsense mutations (R648X and R704X), two
missense mutations (S270R and L278F), and
one acceptor splice site mutation that would
result in a disruption of exon 5, which encodes
D2 (between arrows 1 and 2). The R648X and
R704X mutations have been previously
observed in patients with Dent’s disease [3, 13].
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DNA sequence analysis of the CLCN5 gene
Leukocyte DNA was extracted and used with CLCN5
specific primers for PCR amplification utilizing conditions
previously described [3, 13–15]. The DNA sequence of the
PCR products was determined by the use of Taq polymer-
ase cycle sequencing and a semi-automated detection sys-
tem (ABI373A sequencer; Applied Biosystem, Foster City,
CA, USA) [3, 13–15]. DNA sequence abnormalities were
confirmed by restriction endonuclease analysis of genomic
PCR products obtained by use of the appropriate primers
or by sequence specific oligonucleotide (SSO) hybridiza-
tion analysis [3, 13–15]. In addition, DNA sequence abnor-
malities were also demonstrated to be absent as common
polymorphisms in the DNA obtained from 56 unrelated
normal Japanese individuals (54 females, 2 males).
Functional expression in Xenopus oocytes
Wild-type and mutant CLC-5 s were expressed in Xeno-
pus oocytes as previously described [3, 13, 14]. A cDNA
encoding the human CLC-5 protein was inserted into the
expression vector PTLN [24]. Mutations were introduced
by recombinant PCR. Capped cRNA was synthesized using
SP6-RNA polymerase after linearization of the construct.
About 10 ng of cRNA was injected into manually defollicu-
lated Xenopus oocytes and incubated for two days at 18°C.
Currents were measured using standard two-electrode volt-
age-clamp technique using a Turbo TEC-05 amplifier NPI,
(Tamm Germany) and pCLAMP software (Axon Instru-
ments). Measurements were carried out in ND96 (96 mM
NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES
pH 7.4). The oocyte membrane was held at the resting
potential and stepped for 500 msec to potentials starting
from 2100 to 180 mV in 20 mV steps. Currents were
determined at a membrane potential of 180 mV. Results
were expressed as mean values 6 SD.
Determination of protein expression in Xenopus oocytes
Oocytes were pooled after measurement and stored
at 220°C. After homogenization in 5 mM EDTA, 10 mM
Table 1. Clinical and biochemical findings in 13 members from five kindreds with Dent’sJapan disease
Family 1 2 3 4 5 Normal
child (adult)Patient 1 2 3 4 5 6 7 8 9 10 11 12 13
Age years 37 14 6 31 5 45 45 15 13 50 18 45 16
Sex F M M F M F M M M F M F M
Urine
Protein — 21 21 6 21 21 — 21 21 — 21 6 11 —
b2-microglobulin, mg/liter 1460 97900 132300 344 49400 610 60 95400 120000 580 134200 636 106000 ,320 (,250)
Occult blood 11 11 6 — 11 11 — 11 11 — 11 — 11 —
Ca/Cr % 9 6 17 NT 30 21 18 30 40 NT 16 NT 24 ,25 (,20)
Aminoaciduria NT NT NT — 1 — — 1 1 NT — NT NT —
Glycosuria — — — — — — — 1 1 — — — — —
Serum
Creatinine, mg/100 ml 0.7 1.1 0.5 NT 0.3 0.6 0.9 0.7 1.0 NT 0.7 0.5 0.5 0.1–0.8 (0.6–1.5)
Cl, mEq/liter 103 97 101 NT 105 105 108 103 108 NT 104 105 105 100–108
Ca, mg/100 ml 9.8 10.8 9.7 NT 9.2 9.8 9.4 9.8 9.6 NT 10.1 9.7 8.0 9.0–10.6
P, mg/100 ml 3.4 5.2 4.3 NT 4.6 3.8 4.4 5.1 3.1 NT 3.9 4.5 4.5 3.8–5.6
Nephrocalcinosis
Ultrasonography — 1 1 NT NT NT NT 1 1 NT — NT NT —
CT NT 1 1 NT 1 NT NT 1 1 NT — NT 1 —
Renal biopsy NT NT NT NT NT NT NT
Calcification 1 1 1 1 — — —
Glomerulosclerosis — 1 1 1 — 1 —
Tubular atrophy — — 1 1 — 1 —
Abbreviations are: Ca, calcium; Cr, creatinine; Cl, chloride; P, phosphate; CT, computerized tomography. All values refer to those obtained on early
morning samples after an overnight fast. Signs are: 1, present; —, absent; NT, not tested. Serum concentration of sodium, potassium, urate, magnesium
and blood urea nitrogen were normal in all individuals.
Table 2. CLCN5 mutations in families with Dent’sJapan disease
Family Codon Base change
Amino acid
change
Restriction enzyme
change/SSO Predicted effect
Nonsense mutations
1 648 CGA3TGA Arg3Stop TaqI Loss of 98 amino acids
2 704 CGA3TGA Arg3Stop BslI Loss of 42 amino acids
Missense mutations
3 270 AGC3CGC Ser3Arg AluI ?
4 278 TTG3TTC Leu3Phe SSO ?
Acceptor splice site
mutation
5 intron 4 ag3cg SmaI Disruption of D2
Abbreviation SSO is sequence specific oligonucleotide.
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Tris-HCl and a protease inhibitor mix (Complete;
Boehringer Mannheim, Mannheim, Germany) on ice,
the yolk platelets were removed by three low speed cen-
trifugations. From the supernatant the equivalent of 2
oocytes was dissolved in SDS-Laemmli buffer and loaded
onto a 6% SDS-PAGE. After separation the proteins
were blotted on PVDF-membranes and CLC-5 protein
detected using a rabbit polyclonal antiserum raised against
a peptide encompassing the 13 carboxyterminal amino
acid residues of hCLC-5 [25]. Detection was carried
out using a ProteinA-peroxidase based kit (Renaissance;
DuPont).
Fig. 2. Detection of mutation in exon 8 in
family 3, affected with Dent’sJapan disease, by
restriction enzyme analysis. DNA sequence
analysis of the two affected males II.1 and II.2
revealed an A to C transition at codon 270
(panel A), thus altering the wild-type sequence,
AGC, encoding a serine (S) to the mutant
sequence, CGC, encoding an arginine (R). This
missense mutation (S270R) also resulted in the
loss of a AluI restriction enzyme site (AG/CT).
PCR amplification and AluI digestion (panel B)
would result in four products of 195 bp, 145 bp,
48 bp (not shown) and 39 bp (not shown) from
the normal sequence (N) but only three
products of 195 bp, 184 bp and 48 bp (not
shown) from the mutant sequence (II.1 and
II.2), as is illustrated in the restriction map
(panel C). The mother I.2 is heterozygous for
the wild-type and mutant alleles, the father I.1
is hemizygous for the wild-type allele, and the
two affected boys (II.1 and II.2) are hemizygous
for the mutant alleles. Thus, the mutation
(S270R) is co-segregating with the disease. In
addition, this S270R mutation was not present
in 56 unrelated, normal (N), Japanese
individuals (54 females, 2 males), thereby
indicating that it is not a common DNA
sequence polymorphism. Individuals shown are:
male (square); female (circle); unaffected
(open); carrier (half-filled); affected (filled).
The standard size marker (M) in the form of
the 1 kb ladder is indicated. Similar restriction
enzyme analysis was used to confirm the
mutations R648X, R704X and the acceptor
splice site mutation, in families 1, 2 and 5
(Table 2), respectively.
Igarashi et al: CLCN5 mutations in Dent’sJapan disease 1853
RESULTS
DNA sequence analysis of the entire 2,238 bp coding
region and exon-intron boundaries of the CLCN5 gene
from one affected member of each of the five families with
Dent’sJapan disease (Table 1) revealed the presence of five
mutations that consisted of two nonsense mutations, two
missense mutations, and one acceptor splice site mutation
(Table 2). The two missense mutations (S270R and L278F)
in families 3 (Fig. 2) and 4 (Fig. 3), respectively, occurred in
exon 8; the two nonsense mutations (R648X and R704X) in
families 1 and 2, respectively, occurred in exon 11; and the
acceptor splice site mutation in family 5 occurred in intron
4. The S270R mutation resulted from an A to C transition
(AGC3CGC), the L278F mutation resulted from a G to C
transversion (TTG3TTC), both of the R648X and R704X
mutations resulted from C to T transitions (CGA3TGA),
and the acceptor splice site mutation resulted from an a to
c transition in intron 4 (ag3cg). The S270R, R648X,
R704X, and the acceptor splice site mutations resulted in
an alteration of an AluI, TaqI, BslI, or SmaI restriction
enzyme site, respectively, which facilitated its confirmation
Fig. 3. Detection of mutation in exon 8 in family 4, affected with
Dent’sJapan disease, by SSO hybridization analysis. DNA sequence anal-
ysis of the affected male II.1 revealed a G to C transversion at codon 278
(A), thus altering the wild-type sequence, TTG, which encodes a leucine
(L) to the mutant sequence, TTC, which encodes a phenylalanine (F). This
missense mutation (L278F), which did not result in an altered restriction
enzyme site, was confirmed and demonstrated to co-segregate by the use
of SSO hybridization analysis [3, 13] (B). The affected male II.1 is
hemizygous for the mutant allele and his mother (I.2), who is a carrier
(Table 1), is heterozygous for the mutant (M) and wild-type (WT) alleles.
The absence of this L278F mutation in 56 unrelated, normal (N) Japanese
individuals indicated that it was not a common DNA sequence polymor-
phism. The pedigree symbols indicating the phenotype of each individual
are as described in Figure 2.
Fig. 4. Electrophysiological analysis of Xenopus oocytes expressing hu-
man wild-type (WT) CLC-5 and the mutant S270R (Fig. 2) and L278F
(Fig. 3) channels. The Cl2 currents were measured as previously described
[3, 13, 14] and the averaged (mean 6 SD, N 5 8) whole cell currents
measured at 1 80 mV in the Xenopus oocytes injected with the WT CLC-5
(3.25 6 1.32 mA), the S270R mutant (0.3 6 0.15 mA), the L278F mutant
(1.09 6 0.60 mA), and water control (0.24 6 0.8 mA) are shown. The
mutant channels resulted in either abolished (S270R) or markedly re-
duced (L278F) Cl2 currents.
Fig. 5. Western blot analysis of Xenopus oocyte CLC-5 proteins. Each
lane represents the equivalent of the proteins of 2 Xenopus oocytes
injected with cRNA derived from the human wild-type (WT) CLC-5 and
the mutant S270R (Fig. 2) and L278F (Fig. 3) channels. CLC-5 proteins
were detected using an antibody directed against a carboxyterminal
fragment of CLC-5 [25] to identify fully translated proteins.
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and co-segregation with the disorder in each family (Fig. 2).
The L278F mutation, which was not associated with an
altered restriction enzyme site, was confirmed by SSO
hybridization analysis (Fig. 3). The absence of each of the
five DNA sequence abnormalities in 110 alleles from 56
unrelated, normal Japanese individuals (54 females, 2
males) established that these abnormalities were mutations
and not polymorphisms that would be expected to occur in
.1% of the population. The two nonsense mutations,
R648X and R704X, which predict truncated CLC-5 chan-
nels that lack the 98 and 42 amino acids, respectively, have
been previously observed in other patients with Dent’s
disease [3, 13]. The effects upon CLC-5 of such nonsense
mutations, which have been previously assessed, are likely
to be a loss of function [13]. The acceptor splice site
mutation in intron 4 that had not been previously observed
is likely to result either in exon 5 skipping, or a partial or
complete retention of intron 4 due to use of cryptic or
alternate splice sites, respectively. The consequent effects
on CLC-5 are likely to be a disruption of transmembrane
domain 2, D2, (Fig. 1) with a resulting loss of function. The
effects on CLC-5 of the two missense mutations, S270R
and L278F, which both reside in the loop between the
putative transmembrane domains D5 and D6 (Fig. 1), are
more difficult to predict. The S270R mutation is associated
with the replacement of an uncharged and polar amino acid
(serine, S) for a charged amino acid (arginine, R), while the
L278F mutation represents a more conservative amino acid
exchange of uncharged and hydrophobic amino acids
[leucine, (L) for phenylalanine (F)]. Thus, the S270R
mutation is likely to be associated with a greater dysfunc-
tion of CLC-5 when compared to that associated with the
L278F mutation. A functional assessment of these mutant
CLC-5s in Xenopus oocytes revealed that the S270R muta-
tion was associated with an abolishment of Cl2 currents,
while the L278F resulted in a marked reduction, to about
30% of wild-type CLC-5, in chloride currents (Fig. 4).
Western blot analysis to determine the overall protein
levels in the measured Xenopus oocytes demonstrated no
significant differences between the expression of the mu-
tated and wild-type CLC-5s (Fig. 5).
DISCUSSION
Our results, which have identified 5 CLCN5 mutations (2
nonsense, 2 missense and 1 acceptor splice site mutation) in
Dent’sJapan disease, expand the spectrum of such mutations
associated with this renal tubular disorder. The missense
mutations S270R (Fig. 2) and L278F (Fig. 3), together with
the acceptor splice site mutation (Table 2) represent novel
CLCN5 mutations, whereas the nonsense R648X mutation
(Fig. 1) has been previously observed twice to occur in
Dent’s disease families from Britain [13] and Italy [3], and
the nonsense R704X mutation has also been observed in a
Dent’s disease (XRN variant) family from North America
[13]. Hitherto, a total of 12 CLCN5 mutations had been
reported [14, 15, 17] in Dent’sJapan disease, and the inclu-
sion of the five mutations reported in this study indicate
that the majority of these (70% that is, 12 out of 17) are
likely to result in a truncated or absent CLC-5 channel, and
that the remainder (30% that is, 5 out of 17) are missense
mutations. Of the five missense mutations, two (G513E and
R516W [15]) have been located within the highly conserved
domain D11 [15, 19] and the other three (S270R, L278F
and R280P [14]) are all located within the loop between the
putative transmembrane domains D5 and D6 (Fig. 1).
Heterologous expression in Xenopus oocytes of the mis-
sense mutation R280P resulted in a marked reduction of
Cl2 currents to . 30% of those observed with wild-type
CLC-5 [14]. The expression of the missense L278F muta-
tion resulted in a similar Cl2 current reduction to . 30% of
wild-type CLC-5 (Fig. 4), whereas that of the missense
S270R mutation abolished the Cl2 currents in a manner
similar to those observed with the nonsense W279X muta-
tion [13]. The accumulation of these disease causing muta-
tions in this small (14 amino acids) segment that forms the
putative loop between D5 and D6 may be of importance in
the understanding of CLC-5 function. The residual channel
activity associated with the missense mutations S270R,
L278F and R280P [14] in this region of the protein,
suggests that this putative loop may have a regulatory role
in CLC-5 function. Thus, the results of our study of CLCN5
mutational analysis is Dent’sJapan disease may help to
elucidate further the structure-function relationships of this
renal chloride channel.
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